Israel China Biotechnology (ICB) Ltd (ICB) - Cash Flow Conversion Efficiency

Latest as of June 2021: -0.415x

Based on the latest financial reports, Israel China Biotechnology (ICB) Ltd (ICB) has a cash flow conversion efficiency ratio of -0.415x as of June 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-1.06 Million ≈ $-2.84K USD) by net assets (ILA2.55 Million ≈ $6.83K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Israel China Biotechnology (ICB) Ltd - Cash Flow Conversion Efficiency Trend (2015–2020)

This chart illustrates how Israel China Biotechnology (ICB) Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Israel China Biotechnology (ICB) Ltd (ICB) financial obligations for a breakdown of total debt and financial obligations.

Israel China Biotechnology (ICB) Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Israel China Biotechnology (ICB) Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
edding AG F:EDD3	0.003x
Premium Catering (Holdings) Limited NASDAQ:PC	N/A
Fabrity Holding S.A. WAR:FAB	0.028x
Elve S.A AT:ELBE	0.030x
LANCOR HOLDINGS LTD. NSE:LANCORHOL	0.193x
Cyngn Inc NASDAQ:CYN	-0.174x
NEVADA LITHIUM RESOURCES F:87K	-0.009x
People's Garment Public Company Limited BK:PG	-0.043x

Annual Cash Flow Conversion Efficiency for Israel China Biotechnology (ICB) Ltd (2015–2020)

The table below shows the annual cash flow conversion efficiency of Israel China Biotechnology (ICB) Ltd from 2015 to 2020. For the full company profile with market capitalisation and key ratios, see market cap of Israel China Biotechnology (ICB) Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2020-12-31	ILA470.00K ≈ $1.26K	ILA-4.34 Million ≈ $-11.63K	-9.232x	-312.74%
2019-12-31	ILA1.89 Million ≈ $5.06K	ILA-4.22 Million ≈ $-11.32K	-2.237x	-248.93%
2018-12-31	ILA7.41 Million ≈ $19.87K	ILA-4.75 Million ≈ $-12.74K	-0.641x	-134.10%
2017-12-31	ILA-1.69 Million ≈ $-4.52K	ILA-3.17 Million ≈ $-8.50K	1.880x	+190.81%
2016-12-31	ILA1.91 Million ≈ $5.11K	ILA-3.94 Million ≈ $-10.58K	-2.070x	-213.83%
2015-12-31	ILA5.78 Million ≈ $15.50K	ILA-3.81 Million ≈ $-10.23K	-0.660x	--

About Israel China Biotechnology (ICB) Ltd

TA:ICB Israel Investment Banking & Investment Services

Market Cap

$23.60 Million

ILA8.80 Billion ILA

Market Cap Rank

#25223 Global

#366 in Israel

Share Price

ILA2349.00

Change (1 day)

+0.82%

52-Week Range

ILA200.00 - ILA3650.00

All Time High

ILA3650.00